When a team of Irish scientists made a significant breakthrough in the fight against antibiotic-resistant superbugs, the story quite rightly made world headlines.
Kastus, the Dublin-based technology firm which funded the research, and is bringing the product to market, gained national media attention once again when it recently announced a €1.5m investment.
The funding comes from the Atlantic Bridge University Fund, a major international investment firm which invests in companies built from world-class research.
This ensures Kastus will continue to be well-capitalised as it scales internationally and will be used to grow the company’s customer base. Kastus’ product is a unique antimicrobial solution that kills micro-organisms or inhibits their growth.
This patented technology can be used to protect a range of everyday surfaces —from smartphones to door handles— against deadly bacteria, including MRSA and E. coli.
At StoryLab, we were excited to have been involved in the initial announcement that gained world headlines —from the BBC and RTE to The Guardian and Al Jazeera.
Kastus’s latest investment was picked up by The Irish Times within hours of its release and was printed in the newspaper the following day, as well as in the Irish Examiner, the Irish Independent, the Sunday Business Post and RTE.